Cancerous Patient with COVID-19: Note on Data from the first 3-Month Period of Disease
Open Access
- 1 June 2020
- journal article
- letter
- Published by Scientific Scholar in South Asian Journal of Cancer
- Vol. 9 (02) , 120
Abstract
Coronavirus disease 2019 (COVID-19) is an important pandemic. From its origin in Republic of China,[1] this disease already affects more than 200 countries around the world. The infection can occur in any sex and age group. Malignancy is a possible comorbidity of COVID-19. There are few reported cases of COVID-19 in clinical oncology.[2] Here, the authors would like to share public data reported by local Center for Disease Control and Prevention of the second country where this disease occurred since January 2020.[3] During the 3-month period (January 2020–March 2020), there were 1,651 cases of COVID-19 with 10 deaths. There is a patient with underlying cancer, giving the incidence rate equal to 0.06%. This indexed case is a 48-year-old male patient who works as a singer in a local food shop. He is a known case of colon cancer who had just received surgery and chemotherapy for a few months (the complete chemotherapy was 3 months before). The patient died from respiratory failure on day 5 of hospitalization for antiviral therapy and isolated respiratory care. This is the first data of cancerous patient with COVID-19 from Indochina, an area with a heavy outbreak of COVID-19. According to the reports from Republic of China, malignancy might be associated with poor outcome in COVID-19.[4] Nevertheless, no conclusion should be presently drawn in out setting since it is only one event. It might only imply possibility for poor outcome in case with underlying malignancy. Publication Date: 14 December 2020 (online) © 2020. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd A-12, Second Floor, Sector -2, NOIDA -201301, IndiaKeywords
This publication has 2 references indexed in Scilit: